ARTIFICIAL INTELLIGENCE IS REVOLUTIONIZING PATHOLOGY
Data powered
pathology
Advanced pathology for preclinical research, clinical trials, and decision support
Pathology INTELLIGENCE
Advancing Research, Improving Patient Outcomes
What we do
Biopharma Services
Take advantage of our high quality histopathology research services to generate quantitative pathology end points.
imageDx
Access the the most advanced AI-powered digital assay pathology platform in the cloud.
Clinical Decision Support
Incorporate AI-powered pathology decision support tools to improve patient outcomes.
Pathology Powered By
DATA
Innovative Technology
Quantitative IHC
High quality immunohistochemistry (IHC) combined with whole slide imaging and cell-by-cell quantification to advance your research.
imageDx: NASH
Access the most advanced quantitative NASH and fibrosis data from your human or rodent liver samples.
Trusted By The World's Leading Scientists
Data powered pathology for advanced research & better patient care
News & Articles
Latest research, in the news, or at events.
Reveal Biosciences and QuantumCyte Partner to Offer a New Generation of Multi-omic Data
Precision medicine has come a long way towards benefiting patient outcomes and enhancing research tools. In recent years, the integration of multi-scale omics from genomic, proteomic, and transcriptomic foundations
AI: Advancing Patient Access and Outcomes
Biocom’s 4th Annual Big Data Summit, held October 29, 2019 in La Jolla, CA, brought together thought leaders in artificial intelligence (AI), computational drug discovery, and blockchain technology. Throughout
imageDx: NASH – A New Generation of Quantitative NASH Data
Traditional NAFLD Activity Scoring Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of liver dysfunction, with some estimates suggesting up to 30% of the general
